Parkinson's disease: etiopathogenesis and treatment
J Jankovic, EK Tan - Journal of Neurology, Neurosurgery & Psychiatry, 2020 - jnnp.bmj.com
The concept of 'idiopathic'Parkinson's disease (PD) as a single entity has been challenged
with the identification of several clinical subtypes, pathogenic genes and putative causative …
with the identification of several clinical subtypes, pathogenic genes and putative causative …
Exosomes based strategies for brain drug delivery
Exosome application has emerged as a promising nanotechnology discipline for various
diseases therapeutics and diagnoses. Owing to the natural properties of efficient drug …
diseases therapeutics and diagnoses. Owing to the natural properties of efficient drug …
[PDF][PDF] Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01
J Piao, S Zabierowski, BN Dubose, EJ Hill, M Navare… - Cell stem cell, 2021 - cell.com
Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia
nigra leading to disabling deficits. Dopamine neuron grafts may provide a significant …
nigra leading to disabling deficits. Dopamine neuron grafts may provide a significant …
Engineering of magnetic nanoparticles as magnetic particle imaging tracers
Magnetic particle imaging (MPI) has recently emerged as a promising non-invasive imaging
technique because of its signal linearly propotional to the tracer mass, ability to generate …
technique because of its signal linearly propotional to the tracer mass, ability to generate …
[PDF][PDF] Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use
Human pluripotent stem cells show considerable promise for applications in regenerative
medicine, including the development of cell replacement paradigms for the treatment of …
medicine, including the development of cell replacement paradigms for the treatment of …
Co-transplantation of autologous Treg cells in a cell therapy for Parkinson's disease
The specific loss of midbrain dopamine neurons (mDANs) causes major motor dysfunction
in Parkinson's disease, which makes cell replacement a promising therapeutic approach …
in Parkinson's disease, which makes cell replacement a promising therapeutic approach …
Alpha-Synuclein aggregation pathway in Parkinson's disease: current status and novel therapeutic approaches
M Vidović, MG Rikalovic - Cells, 2022 - mdpi.com
Following Alzheimer's, Parkinson's disease (PD) is the second-most common
neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile …
neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile …
Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons
TS Pearson, N Gupta, W San Sebastian… - Nature …, 2021 - nature.com
Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare genetic disorder
characterized by deficient synthesis of dopamine and serotonin. It presents in early infancy …
characterized by deficient synthesis of dopamine and serotonin. It presents in early infancy …
Mesenchymal stem cell-derived exosomes as a new therapeutic strategy in the brain tumors
E Ghasempour, S Hesami, E Movahed… - Stem Cell Research & …, 2022 - Springer
Brain tumors are one of the most mortal cancers, leading to many deaths among kids and
adults. Surgery, chemotherapy, and radiotherapy are available options for brain tumor …
adults. Surgery, chemotherapy, and radiotherapy are available options for brain tumor …
In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids
Ventral midbrain dopaminergic neurons project to the striatum as well as the cortex and are
involved in movement control and reward-related cognition. In Parkinson's disease …
involved in movement control and reward-related cognition. In Parkinson's disease …